BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 8569187)

  • 1. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints.
    Chubinskaya S; Kuettner KE; Cole AA
    Lab Invest; 1999 Dec; 79(12):1669-77. PubMed ID: 10616215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
    Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
    Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human knee and ankle cartilage explants: catabolic differences.
    Eger W; Schumacher BL; Mollenhauer J; Kuettner KE; Cole AA
    J Orthop Res; 2002 May; 20(3):526-34. PubMed ID: 12038627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV; Squires G; Poole AR
    J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
    Ohta S; Imai K; Yamashita K; Matsumoto T; Azumano I; Okada Y
    Lab Invest; 1998 Jan; 78(1):79-87. PubMed ID: 9461124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
    Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
    Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
    Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
    Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study.
    Pelletier JP; Faure MP; DiBattista JA; Wilhelm S; Visco D; Martel-Pelletier J
    Am J Pathol; 1993 Jan; 142(1):95-105. PubMed ID: 8424468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.